Okay, let's tackle this question. The question is about calcium channel blockers and which one has a predominant peripheral action. The options aren't listed, but the correct answer is given as option C, which I'm assuming is Nifedipine.

First, I need to recall the different classes of calcium channel blockers. There are two main types: dihydropyridines (like nifedipine, amlodipine) and non-dihydropyridines (like verapamil, diltiazem). Dihydropyridines primarily affect peripheral vasculature, causing vasodilation, which makes them useful for hypertension and angina. Non-dihydropyridines have more effect on the heart, especially the AV node, so they're used for rate control in arrhythmias.

The question is asking for the one with predominant peripheral action. So dihydropyridines are the right group here. Nifedipine is a classic example. The other options might be verapamil or diltiazem, which are non-dihydropyridines.

Wait, the question is from 2006, so maybe the options are A: Verapamil, B: Diltiazem, C: Nifedipine, D: Dronedarone or something else. I need to make sure the incorrect options are other CCBs.

In the explanation, the core concept is the classification of CCBs and their mechanisms. The correct answer is Nifedipine because it's a dihydropyridine acting on peripheral blood vessels. The wrong options are non-dihydropyridines or other drugs with different mechanisms.

Clinical pearl: Remember that dihydropyridines (DHP) are peripheral, non-DHP are cardiac. Mnemonic: DHP = legs (peripheral), non-DHP = heart (cardiac). Also, DHPs can cause reflex tachycardia due to vasodilation, while non-DHPs have negative inotropic and chronotropic effects.

So putting it all together, the correct answer is C, Nifedipine. The explanation should cover the mechanism, why others are wrong, and the key point to remember.

**Core Concept**
Calcium channel blockers (CCBs) are classified into dihydropyridines (DHPs) and non-DHPs. DHPs, like nifedipine, primarily cause peripheral vasodilation by blocking L-type calcium channels in vascular smooth muscle, reducing systemic vascular resistance. Non-DHPs (e.g., verapamil, diltiazem) target cardiac tissue, inhibiting AV nodal conduction and myocardial contractility.

**Why the Correct Answer is Right**
Nifedipine is a dihydropyridine CCB with high selectivity for vascular smooth muscle over cardiac tissue. It binds to L-type calcium channels in peripheral arteries, reducing intracellular calcium influx and causing vasodilation. This mechanism makes it effective for hypertension and angina due to its predominant peripheral action. Its minimal cardiac effects distinguish it from non-DHP CCBs.

**Why Each Wrong Option is Incorrect**
**Option A:** Likely verapamil. It is a non-DHP CCB with strong AV nodal blockade and

✓ Correct Answer: C. Nifidepine